POSTANTIBIOTIC EFFECTS AND POSTANTIBIOTIC SUB-MIC EFFECTS OF BENZYLPENICILLIN ON VIRIDANS STREPTOCOCCI ISOLATED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS

被引:10
作者
KIKUCHI, K [1 ]
ENARI, T [1 ]
MINAMI, S [1 ]
HARUKI, K [1 ]
SHIBATA, Y [1 ]
HASEGAWA, H [1 ]
KATAHIRA, J [1 ]
TOTSUKA, K [1 ]
SHIMIZU, K [1 ]
机构
[1] TOKYO WOMENS MED COLL,DEPT MED,SHINJUKU KU,TOKYO 162,JAPAN
关键词
D O I
10.1093/jac/34.5.687
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We investigated the postantibiotic effects (PAEs) and the postantibiotic sub-MIC effects of benzylpenicillin on three strains of viridans streptococci isolated from infective endocarditis patients. The PAEs of benzylpenicillin on penicillin tolerant Streptococcus sanguis TW-70 (0.4-3.9h), penicillin tolerant S. sanguis TW-80 (0.3-6.3 h) and nontolerant Streptococcus oralis TW-186 (0.5-3.1 h) were dependent on exposure time. The PAEs were not concentration dependent for S. sanguis TW-70 and S. sanguis TW-80 above the MIC, and for S. oralis TW-186 above 16 x MIC. The antimicrobial effects of benzylpenicillin at sub-MIC concentrations were examined in bacteria pretreated with benzylpenicillin (8 x MIC) for 2 h and compared with untreated bacteria. At the sub-MICs tested, the regrowth of pretreated S. oralis TW-186 cells was more prolonged than that of untreated cells and bactericidal action was seen only in pretreated cells. These effects (so-called 'postantibiotic sub-MIC effects') were not observed in penicillin tolerant S. sanguis TW-70. The presence of the postantibiotic sub-MIC effect may be an important factor in determining the dosing regimen for infective endocarditis.
引用
收藏
页码:687 / 696
页数:10
相关论文
共 38 条
[1]   THERAPEUTIC SIGNIFICANCE OF PENICILLIN TOLERANCE IN EXPERIMENTAL STREPTOCOCCAL ENDOCARDITIS [J].
BRENNAN, RO ;
DURACK, DT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :273-277
[2]  
Craig WA, 1991, ANTIBIOTICS LAB MED, P403
[3]   PHARMACOKINETIC AND PHARMACODYNAMIC REQUIREMENTS FOR ANTIBIOTIC-THERAPY OF EXPERIMENTAL ENDOCARDITIS [J].
CREMIEUX, AC ;
CARBON, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2069-2074
[4]   INVITRO ACTIVITY OF THE NEW PENEMS FCE-22101 AND FCE-24362 ALONE OR IN COMBINATION WITH AMINOGLYCOSIDES AGAINST STREPTOCOCCI ISOLATED FROM PATIENTS WITH ENDOCARDITIS [J].
DORNBUSCH, K ;
HENNING, C ;
LINDEN, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 :109-117
[6]   PARADOXICAL RESPONSE OF ENTEROCOCCUS-FAECALIS TO THE BACTERICIDAL ACTIVITY OF PENICILLIN IS ASSOCIATED WITH REDUCED ACTIVITY OF ONE AUTOLYSIN [J].
FONTANA, R ;
BOARETTI, M ;
GROSSATO, A ;
TONIN, EA ;
LLEO, MM ;
SATTA, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :314-320
[7]   INTEGRATION OF PHARMACOKINETICS AND PHARMACODYNAMICS OF METHICILLIN IN CURATIVE TREATMENT OF EXPERIMENTAL ENDOCARDITIS [J].
GENGO, FM ;
MANNION, TW ;
NIGHTINGALE, CH ;
SCHENTAG, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (06) :619-631
[8]  
HANDWERGER S, 1985, REV INFECT DIS, V7, P368
[9]   SIGNIFICANCE OF PENICILLIN TOLERANCE INVIVO - PREVENTION OF EXPERIMENTAL STREPTOCOCCUS-SANGUIS ENDOCARDITIS [J].
HESS, J ;
DANKERT, J ;
DURACK, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (06) :555-564
[10]   POSTANTIBIOTIC EFFECT OF PENICILLIN PLUS GENTAMICIN VERSUS ENTEROCOCCUS-FAECALIS INVITRO AND INVIVO [J].
HESSEN, MT ;
PITSAKIS, PG ;
LEVISON, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :608-611